Ozempic (semaglutide) is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) licensed in the UK for the treatment of type 2 diabetes mellitus
Please enter your contact details below and the reason for your discovery call and we will get back to you to arrange a suitable time for your FREE 15 Minute Discovery Call
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER In August, a Louisiana woman sued Novo Nordisk, the manufacturer of Ozempic and Wegovy, and Lilly, which makes another GLP-1 agonist, Mounjaro, claiming that the companies "downplayed the severity of gastrointestinal events caused by Ozempic and Mounjaro never, for example, warning of the risk of gastroparesis (paralyzed stomach) or gastroenteritis." The woman, who used Ozempic for more than a year before switching to Mounjaro last month, alleged she was "severely injured as a result" of using both drugs, the suit stated
Some patients regain weight mainly because hunger and cravings return
By assisting with metabolism and cellular health, Vitamin B12 can contribute to improved focus, balanced mood, and day-to-day wellness
